NOVO NORDISKDRN revenue breakdown overview

NOVO NORDISKDRN revenue for the last year amounted to 249.17 B BRL, the most of which — 233.18 B BRL — came from its highest performing source at the moment, Diabetes and Obesity Care, the year earlier bringing 154.79 B BRL. The greatest contribution to the revenue figure was made by United States — last year it brought NOVO NORDISKDRN 143.64 B BRL, and the year before that — 91.77 B BRL.